Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may ...
NEW YORK (Reuters Health) - Drugs used in the hope of slowing multiple sclerosis progression may help some patients, but at a very high cost, according to a study out Wednesday. The medications in ...
3don MSN
Machine learning and cell imaging combine to predict effectiveness of multiple sclerosis medication
Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will ...
Those who prescribe larger amounts of MS drugs were more likely to have received payments, and those who got payments were ...
The EU’s General Court struck down Biogen’s extra year of market protection for Tecfidera, siding with generics in a ruling ...
Even women with more severe MS cases are less likely than men to get critical treatments, a new study finds. Women under age 40 with multiple sclerosis are 8 percent less likely than men to receive ...
HealthDay News — Nearly 80 percent of neurologists prescribing multiple sclerosis (MS) drugs receive payments from industry, according to a study published online Aug. 26 in BMJ Open.
A new study found that most therapies used to treat multiple sclerosis (MS) were linked to a higher risk of low birth weight but not miscarriage, premature birth, and major birth defects. The study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback